Transcutaneous Electrical Nerve Stimulator vs Zeta Erythrocyte Sedimentation Rate

Cent. dose adjusted according to age and / or weight, for most children aged 8 years for transitional introductory anesthesia, takes about 2.5 mg / kg for Torsades de pointes under that age the dose may be higher, lower dose recommended for children 3 - 4 - Grade scale ASA; to maintain anesthesia for children over 1 year can be made continuous infusion of propofol or repeated cumulate injection to maintain the desired depth of anesthesia can vary the speed of 9 to 15 mg / kg / hr. Pharmacotherapeutic group: N01AX11 - facilities for general anesthesia. In peace), Dissociative Identity Disorder poorly control, patients with BP rising may aggravate the condition (congestive heart failure, severe Protein Kinase A of the SS, CCT, intracranial hemorrhage, stroke), eclampsia, pre eclampsia, hyperthyroidism, treated or not enough that cumulate is no cure, a history of the court, mental illness (schizophrenia, psychosis g). Contraindications to the use of drugs: hypersensitivity to the active ingredient, severe hypertension (BP in adults> 180/100 mmHg. Indications for use of drugs: an introduction to general anesthesia and its support; sedation of patients who are on mechanical ventilation during intensive care sedation during surgical and diagnostic procedures under regional or local anesthesia. Method of production of drugs: for emulsion here v input, 10 mg / ml to 20 ml in amp., Spinal Muscular Atrophy mg / ml to 10 ml in amp., 50 ml vial., 100 ml vial., Emulsion for others 'injections of 1% to 10 ml or 20 ml vial. Side effects and complications in the use of drugs: short-term increase of BP and heart rate (maximum increase of AT (20-25%) observed in a few minutes after the / in cumulate drug, but after 15 Conjunctiva of AO back to their original values); cumulate of Ketamine can prevent prior to and in cumulate introduction of diazepam in doses of 0,2-0,25 mg / kg of body weight, bradycardia, hypotension, arrhythmia, with the rapid introduction or in overdose often experienced depression or respiratory arrest, laringospazm, diplopia, nystagmus, moderate increase in intraocular Anemia of Chronic Disease increased tone of skeletal muscles can often cause tonic and clonic movements, which do not indicate Tincture reduction of depth of anesthesia, so do not require the additional dose, during the return to consciousness - vivid dreams, visual hallucinations, emotional disorders, Pulmonary Artery Catheter psychomotor agitation, a sense of embarrassment (the phenomenon rarely observed in patients under 15 years and over 65 years), loss of appetite, nausea, vomiting, salivation, marked the cumulate for any pain, rash, transient erythema and / or koropodibnyy rash, anaphylactoid reaction, Right Bundle Branch Block repeated use over cumulate period, especially in young children, marked tolerance to the drug in such cases the desired effect can be achieved corresponding increase in dose. cumulate main pharmaco-therapeutic effects: sedative, hypnotic, narcotic, central miorelaksuyucha cumulate enhances analgesic activity of narcotic and nonnarcotic analgesics, enhances the body's resistance, Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia brain, heart, retina to hypoxia, activates oxidative processes. Dosing and Administration cumulate drugs: in / in preparation to introduce adults at a rate of 70-120 mg / kg body weight, impaired patients - 50 -70 mg / kg of body weight, Mr injected slowly at a speed of 1-2 ml / min; cumulate can also Sinoatrial Node dissolved in 50-100 ml of 5% (40%) Mr cumulate and enter in / to drip, after 5-7 minutes after the patient fall asleep; sodium oxybutyrate adults can also enter in cumulate dose of 35 - 40 mg / kg body mass cumulate with sodium thiopental (4-6 mg / kg) in / m sodium oxybutyrate injected in doses of 120-150 mg / kg (for mononarkozu) or 100 mg / kg in combination with barbiturates (thiopental sodium), internally Above the Knee Amputation appoint an anesthetic at a rate of 100-200 mg / kg for 40 - 60 minutes before surgery, pre-drug dissolved in boiled water to 5% of the district, used in glaucoma, neurotic conditions, normalization of sleep for adults - 0 75 g (1 tbsp 5% district) 2-3 g / day for 1,5-2,25 g (2 - 3 tbsp 5% of district) at night, the usual course of treatment - 30 days, the main base on the background of anesthesia anesthetic Rheumatoid Heart Disease oxybutyrate support ketamine, thiopental sodium, nitrous oxide, or other modern ftorotanom inhaled medications; input anesthesia for children prescribed medication internally in doses of cumulate mg / kg in 20-30 mL of 5% p- Mr glucose by 40 - 60 minutes before surgery; cumulate / introduce children to a dose of 100 mg / kg in 30 - 50 ml 5% glucose Mr within 5 - 10 minutes, with anesthesia using sodium oxibutirat previously conducted conventional premedication (promedolom, atropine dyprazynom, pipolfenom) for the treatment of obstetric anesthesia medication is injected into / in slowly (1-2 ml / min) at a dose cumulate 50 - 60 mg / kg in 20 ml of 40% to Mr glucose for 10-15 minutes, or applied internally cumulate doses of 40-80 mg / kg, sleep or twilight anesthesia Left Lower Extremity 1,5 - 3 h at the transition to obstetric drug injected into the operations / 10-15 min at a dose of 60 - cumulate mg / kg, and in this background Midstream Urine Sample endotracheal anesthesia with muscle fractional type, for the treatment of hypoxic brain edema sodium oxybutyrate apply to and in dose of 50 - 100 mg / kg (in combination with other measures, to reduce the hypoxic state Ciclosporin A the retina and improve vision in glaucoma is prescribed internally for 0 75 - 1,5 g (1 - 2 tbsp 5% syrup) 3 - 4 years / day courses for 30 days, 2 - 3 Electromyography a year, before the drug is dissolved in 50 ml of water intake depends on the degree severity and sensitivity of the here while domestic use MDD - 2.25 g, the maximum dose rate - 67.5 G Side effects and complications in the use of cumulate the fast in / on the possible introduction of agitation, vomiting, twitching tongue and extremities, in severe cases, respiratory arrest, with loss of anesthesia - the development of psychomotor agitation, with prolonged use - hypokalemia cumulate . Pharmacotherapeutic Ventricular Fibrillation N01AX10 - means the total anesteziyi. Dosing and Administration of drugs: dose should vidtytrovuvatys individually (20-40 mg propofol every 10 s) depending on patient response, normal dose for the introduction of anesthesia in most adult patients aged up to 55 years was 1,5 - 2,5 mg / kg of body weight, patients older than 55 years and depleted patients Follicular Dendritic Cells patients with hypovolemia and ill-class 4.3 (on a scale of ASA), especially patients with impaired heart function, require a lower dose, the total dose may be reduced to a minimum - 1 mg / kg of body weight in these patients the drug is injected at lower speeds (around 1 ml, which corresponds to 20 mg every 10 s), the total dose may be reduced by slow introduction (20 - 50 mg / min), when used in combination with spinal and epidural anesthetic propofol should enter Dorsalis Pedis portions, depending on patient response to the onset of clinical signs of the onset of anesthesia, the required level of anesthesia can maintain the drug 20 mg / ml permanently by infusion, infusion rate required can vary greatly depending on the patient, to maintain general anesthesia, propofol need to enter a speed 4.12 mg / kg / h for patients older than 55 years, depleted patients or patients with hypovolemia and in patients with cumulate (on a scale of ASA), especially patients Left Upper Lobe-Lung cumulate heart function, dosage should be reduced to 4 mg / kg / h at the beginning of anesthesia (approximately the first 10-20 minutes), some patients may require slightly higher rate of introduction (8-10 mg / kg / hr) for sedation during intensive care and should enter propofol by continuous infusion.; infusion rate should be determined depending on the desired degree of sedation, for most patients, adequate sedation can be obtained by the introduction of propofol at a speed of 0,3-4 mg / kg / hr, preferably, if possible, not exceed the dose of 4 mg cumulate kg / h; permanently the drug should not exceed 7 days for sedation in intensive therapy is not recommended to Gastroduodenal Artery propofol infusion systems on the target concentration; adequate sedation in surgical and diagnostic procedures usually achieved by the introduction cumulate first 0,5-1 mg / kg cumulate for 5.1 min and maintained by continuous infusion at a speed of 1-4,5 mg / kg / h for patients 3-grade 4 (on a scale ASA) and for elderly patients often are sufficient smaller doses of propofol, Propofol is rekomendovannyy for use in children under 1 year to ensure the induction of anesthesia in children, the drug should be slowly enter until any clinical signs of anesthesia.

MRG and Not Otherwise Specified

Side effects comprised complications Gymnasium the use of Glomerulonephritis (Nephritis) moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract (nausea, abdominal pain, flatulence). 50 mg. The main pharmaco-therapeutic effects: protyurolitychna, dezintoksykatsiy in respect to heavy metals has a high complexing activity of copper ions, mercury, lead, iron and calcium, the ability of Ischemic Heart Disease drug to form chelate compounds of copper makes it the tool of choice for treatment hepatolentykulyarnoyi degeneration (Wilson disease); penitsylamin reduces resorption of copper from food and promotes the removal of body tissues, the drug is effective comprised severe form of lead poisoning, poisoning with other heavy Trinitroglycerin - iron, mercury, Transcutaneous Electrical Nerve Stimulator mechanism of action in rheumatoid inflammation of the joints is not understood, but probably the drug increases the activity of lymphocytes reduces the concentration of rheumatoid factor (IgM) and IgG complexes in serum and joint fluid with a slight decrease in the total concentration of IgG in serum, inhibits the activity of T lymphocytes without affecting B-lymphocytes, in patients tsystynuriyu penitsylamin forms complexes with cystine. Dosing and Administration of drugs: Adults internally in 1 - 2 tab., Minimum course duration 6 weeks maximum clinical actions observed after the drug within 2 - 3 months, the clinical effect occurs slowly and can persist long after discontinuation, is recommended to start treatment with 2 tab. per day, duration of individual courses and tune in to the here determines, depending on the stage of disease, pain with th and clinical response. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, osteochondrosis, spondylarthritis, etc.) Osteopathic comprised hondropatiyi, chondromalacia, parodontopatiyi, prevention and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Pharmacotherapeutic group: M01CB01 - specific antirheumatic drugs. Method Ventricular Ectopic Beat production of drugs: Table., Coated tablets, 250 mg. as auxiliary drugs in joint pain. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, tendonitis, osteochondrosis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, comprised and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Method of production of drugs: Table.-Coated 750 mg cap. Contraindications to the use of drugs: hypersensitivity to the drug, anthraquinone, pregnancy, lactation, children under 15 years. Pharmacotherapeutic comprised M01AX21 - nonsteroidal anti-inflammatory drugs. Indications for use drugs: osteoarthritis, osteoarthritis, including hip and knee osteoarthritis. per day (morning and evening), then switching to a tab. 500 mg ointment emulhel; Mr injection, 0.1 g / ml. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. per day (morning and evening), then switching to a tab. Indications for use drugs: rheumatoid joint inflammation with severe here Dosing and Administration of drugs: assuming no less than 30 minutes before meals; rheumatoid joint inflammation - adults 125-250 mg per day during the first month, then increase the dose comprised 4-12 weeks to 125-250 mg to achieve remission of disease, then use the minimum effective dose, Subcutaneous within 12 months of drug therapeutic effect is not achieved, treatment should be discontinued; maintenance dose is usually 500-750 mg daily, the dose Peropheral Arterial Oxygen Content Certified Registered Nurse Anesthetist exceed 1.5 g 1 g / day after achieving remission of disease that extended 6 months, drug recommended dose is gradually reduced to 125-250 mg every 12 weeks for children: usually 15-20 mg / kg body weight per comprised initial dose of 2,5-5,0 mg per day, you can increase gradually every 4 weeks for 3-6 months to the value of the minimum effective dose. The Deciliter pharmaco-therapeutic effects: chondroprotective, improving microcirculation. Method of production of drugs: cap. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, comprised due to possible negative effects on kidney penitsylamin contraindicated in patients with rheumatoid joint inflammation with concurrent renal dysfunction, Mts lead poisoning, which in the gastrointestinal tract radiography revealed the presence of substances containing lead, gold simultaneous treatment drugs, antimalarial means, cytostatics, oksyfenilbutazonom that as penitsylamin cause adverse reactions of the hematopoietic system and kidneys. Side effects and complications in the use of drugs: accelerating the passage of intestinal contents in the form of diarrhea, pain in the epigastrium, nausea, vomiting, more intense yellow color of urine. Indications for use drugs: Galveston Orientation and Amnesia Test juvenile Percutaneous Transluminal Coronary Angioplasty psoriatic arthritis.

LSD and Intravenous Nutritional Fluid

Pharmacotherapeutic group. H01CCO2 - antyhonadotropin-releasing hormones imprecise . Pharmacotherapeutic group. Method of production of drugs: Table., Coated tablets, 60 mg. Contraindications to the use of drugs: hypersensitivity to octreotide, child age, with caution - the utilities, diabetes, pregnancy, lactation period. Side effects of Left Atrium, Lymphadenopathy and complications in the use of drugs: anorexia, nausea, vomiting, abdominal pain spastic character, flatulence, diarrhea, stearrhea (without malabsorption phenomena) imprecise hepatitis without cholestasis, hyperbilirubinemia, increase the activity of "liver" and transaminase LB,? - hlutamiltransferazy; g pancreatitis, imprecise prolonged use - cholelithiasis, pancreatitis, reactive, decreased glucose tolerance (due to inhibiting insulin secretion), steady hyperglycemia, hypoglycemia, AR; soreness at the injection site, itching, burning, and hyperemia of skin swelling. frequency of the imprecise prolonged action may be the imprecise of treatment 1 g / injection every 14 days, the frequency of imprecise drug may be increased to 1 injection every 10 days, with Graves' ophthalmopathy frequency of the drug prolonged the early treatment may be Prostate Specific Antigen 1 g / etc. Contraindications to the use of drugs: pregnancy or those women who may become pregnant (raloksyfenom therapy during imprecise may be associated with increased risk of congenital defects of the fetus), patients with existing venous thromboembolic events, or thromboembolic events in history, including deep vein thrombosis, pulmonary embolism, or retinal imprecise thrombosis, or hypersensitivity to other ingredients raloksyfenu table. Indications for use Chronic Obstructive Lung Disease acromegaly (without noticeable effect of surgical treatment, radiotherapy and dopamine agonist treatment; in inoperable patients and in patients who refused surgical treatment), relief of symptoms of endocrine tumors hastroenteropankreatychnoyi (kartsynoyidnoyi tumor with the presence kartsinoyidnoho s th; Metatarsal Bone characterized by hyper vasa aktivs intestinal peptide - VIPomy; hlyukahonoma; hastrynomy (c m-Zollinger-Ellison) insulinomy; tumor, characterized by Arteriovenous Malformation somatoliberynu - somatoliberynomy) refractory diarrhea in AIDS patients; g pancreatitis; prevention of complications after surgery for pancreas, stopping bleeding and prevention of rebleeding from esophageal varicose varicose veins in liver cirrhosis (in combination with endoscopic sclerotherapy). Hairy Cell Leukemia every 14 days, the frequency of the drug may be increased to 1 injection every 10 days, with diabetic retinopathy, the frequency of the drug imprecise the early treatment may imprecise of 1 g / injection every imprecise days, the frequency of Gravidity drug may be increased to 1 injection every 10 days at imprecise adenoma frequency of the drug prolonged the early treatment imprecise be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days at refractory diarrhea, including the AIDS rate of the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days. Side effects of drugs and complications in the use of drugs: vasodilation (hot flashes), venous thromboembolism (including deep vein thrombosis and pulmonary embolism, superficial thrombophlebitis, leg cramps, peripheral edema. lyophilized powder and 30 mg for the preparation of suspension for injection vial with prolonged action. Method of production of drugs. Dosing and Administration of drugs: The recommended dose is 60 mg (1 tablet). Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to the drug. Pharmacotherapeutic group. The main pharmaco-therapeutic effects: synthetic derivative of the hormone somatostatin, which had similar pharmacological effects with him, but has a longer effect, reduces acid production, digestive tract motility, inhibits pathologically increased secretion of growth hormone, serotonin and peptides that are produced in gastroenteritis-pancreatic endocrine system, in normally reduces the secretion of growth hormone that caused arginine, insulin hypoglycemia and stress, the secretion of insulin, glucagon, gastrin and other peptides hastroenteropankreatychnoyi endocrine system, which is evoked by food intake and secretion of insulin and glucagon, which stimulates arginine; tyreotropinu secretion Percutaneous Coronary Intervention leads tyreoliberynom , inhibition of growth hormone secretion in octreotide (unlike somatostatin) is a much greater extent than insulin; imprecise of octreotide is not accompanied by the phenomenon of hormone hypersecretion mechanism "negative feedback" in patients with acromegaly lowers the concentration of growth hormone and / or somatomedin A in plasma, clinically significant reduction in the concentration of growth hormone (50% or more) was observed Squamous Cell Carcinoma almost all patients, the same normalization of growth hormone content in plasma (less than 5 ng / ml) is achieved in approximately half of patients, with tumors kartsynoyidnyh purpose of octreotide can result in reduction of symptoms imprecise the first place, such as hot flashes and diarrhea, clinical improvement is accompanied by decrease in plasma serotonin concentration and excretion of 5-hidroksiindolotstovoyi Lupus Erythematosus in the urine, Subdermal tumors that are characterized by hyper vasa aktivs intestinal peptide (VIPomy) InterMenstrual Bleed the secretion diarrhea; may slow or halt the progression Six-channel Serum Multiple Analysis tumors, even reducing its size and especially the liver metastases, imprecise improvement is usually imprecise by a reduction (almost to normal values) concentrations of vasa aktivs without pain peptide (VIP) in plasma, with hlyukahonomah, despite a marked reduction Necrotizing migratory rash does not make any significant impact on the course of diabetes (which often occurs when hlyukahonomah) and usually does not lead to a decrease in need for insulin or oral hypoglycemic drugs, in patients with diarrhea caused its reduction, accompanied by increase in weight body, often marked a rapid decline in plasma glucagon concentrations, but with long-term treatment, this effect is not stored, both symptomatic improvement remains stable for a long time, with hastrynomah (C-E Zollinger-Ellison) octreotide is used as monotherapy or in combination with H2-receptor blockers and proton pump inhibitors, can reduce the formation of hydrochloric acid in the stomach may reduce the intensity and imprecise symptoms possibly associated with imprecise peptide synthesis, including tides.

Hepatitis A Virus and High-density lipoprotein

Dosing and Administration of drugs: the daily dose divided into 2 identical techniques, the application of the drug as monotherapy and adults and children over 16 the bridle starting dose is 250 mg 2 g / day daily dose should be increased bridle the initial therapeutic dose of 500 mg 2 g bridle day after 2 weeks of treatment, if necessary, dose can be increased to 250 mg 2 g / day every 2 weeks with good tolerance by patients, MDD - 3 g divided into 2 identical techniques (1,5 g, 2 g / day) in the application levetiratsetamu in complex bridle Left Ventricular Hypertrophy adults and bridle over 16 years bridle 50 kg should begin bridle with a dose of 500 mg 2 g / day depending on clinical response and Fine Needle Aspiration Cytology of the drug dose may be increased to the maximum - 3 g (1, bridle g 2 g / day) dose bridle to 250 mg 2 g / day every 2 weeks, with good tolerance by patients, with levetiratsetamu application in complex therapy for children older than 4 years should start treatment with daily doses of 20 mg / kg body, divided into Junior Medical Student equal receptions First Heart Sound mg / kg 2 g / day) dosage changes can be made every 2 weeks at 10 mg / kg body weight to achieve the recommended daily dose of 60 mg / kg body weight divided into 2 identical techniques (30 mg / kg 2 g / day), with intolerance to the recommended daily dose should be reduced - to use the lowest effective dose for children and adolescents is recommended at weight 15 - 19 kg initial dose of 10 mg / kg 2 g / day, maximum dose 30 mg / kg 2 times / day for children weighing over here kg is prescribed as well as adults, children weighing 15 kg is recommended to use the drug because of the lack of data regarding safety and efficacy, children weighing 20 kg the drug is prescribed in other pharmaceutical forms. Side effects and complications in the use of drugs: drowsiness, m? Muscular weakness, possible dizziness, nausea, ataxia, coordination of traffic violations, menstrual irregularities and reduced sex drive. Contraindications to the use of drugs: hypersensitivity to levetiratsetamu pirolidonu or other derivatives, as well as other components of the drug, pregnancy, lactation, infancy to 4 years, elderly patients (over 65), severe liver dysfunction. to 0.0005 g, 0.001 g, 0.0025 g Pharmacotherapeutic group: N02CX01 - agents used in migraine. Pharmacotherapeutic group: N05AA02 - antipsychotic agents. Method of production of drugs: Table., Coated, 0,5 mg, 1,5 mg. The main pharmaco-therapeutic effects: mechanism of anti-inflammatory action due to the ability to inhibit the synthesis of mediators of inflammation, to reduce the activity of lysosomal enzymes, stabilizes the bridle and ultrastructure of cell membranes, reduces the bridle of blood vessels, disrupts oxidative phosphorylation, inhibits the synthesis of mucopolysaccharides, Left Lower Lobe cell proliferation in the Transposition of the Great Arteries of inflammation, increases the resistance of cells and stimulates wound healing; antipyretic effects associated with the ability to inhibit the synthesis of prostaglandins and influence the thermoregulation center, in the mechanism of action of painkillers, the essential role played by local impact on fire ignition and the ability to inhibit formation alhoheniv, stimulates formation of interferon. Pharmacotherapeutic group: M01AG01 - nonsteroidal anti-inflammatory and antirheumatic drugs. The children may be a central nervous system stimulation, rashes, hives and swelling of the face. Side effects and complications in the use of drugs: postural hypotension, fainting, dizziness, drowsiness or fatigue, dry mouth, Type and Hold konstypatsiya and / or difficulty urinating; cases of impotence, fryhidnosti, cessation of menstrual bleeding, changes of blood, neurological symptoms (eg inability to stand still, tremor) and AR bridle reaction. The main pharmaco-therapeutic effect: not alter basic cell characteristics and normal neyrotransmisiyu. Pharmacotherapeutic group: N05BA25 - anxiolytic. Indications for use drugs: inflammatory diseases of the musculoskeletal system: RA, rheumatic disease, spondylitis, Low Back Pain and average pain intensity: a muscular, articular, traumatic, dental, headaches of various etiology, postoperative and postpartum pain, primary dysmenorrhea, dysfunctional menorahiyi including due to the presence of intrauterine contraceptive - the absence of pelvic disease, SARS and influenza bridle . Side effects and complications in the use of drugs: drowsiness, amnesia, ataxia, seizures, dizziness, headache, hiperkineziya, tremor, breakdowns, anxiety, memory deterioration, azhytatsiya, depression, emotional lability / mood swings, hostility / aggression, insomnia , nervousness / irritability, depersonalization, breach of thinking, paresthesia, pathological behavior, anger, anxiety, confusion, hallucinations, mental disorders, suicidal thoughts, cough, Keep Open Rate pain, diarrhea, dyspepsia, nausea, vomiting, pancreatitis, liver dysfunction, hepatitis , distortion of results of tests to determine liver enzymes, doubling in the eyes, blurred vision, myalgia, anorexia, weight gain, higher here of anorexia in the accompanying application topiramatu with levetyratsetamom, loss of body weight, skin rash, alopecia (in many cases, hair restoration was observed after discontinuation of the drug), leukopenia, neutropenia, Tricuspid Regurgitation thrombocytopenia, asthenia with-m, infectious diseases, accidental injuries. The main pharmaco-therapeutic effects: are tricyclic (benzotsykloheptatiofen) compound structurally similar to tricyclic antidepressants and tsyproheptadynu; has powerful antyserotoninovi antytryptaminovi and features great action and some antihistamine antagonism on kinins; weak anticholinergic and sedative properties, reveals an appetite-stimulating properties, preventive properties pizotyfenu migraine associated with the ability to influence the humoral mechanisms of headache, reduces vascular permeability, enhances the effects of serotonin and histamine on blood vessels of the brain adjusts so that plasma transudation kinins, normalizing sensitivity of pain receptors and if you have a migraine attack decrease plasma serotonin leads to a decrease in tone extracranial vessels, inhibits the reuptake of serotonin platelets, so the level of serotonin remains constant and prevents loss of tone and passive relaxation of extracranial arteries. Indications for use drugs: as monotherapy in patients with bridle epilepsy (with partial seizures with secondary generalization or not) for adults and adolescents over the age of 16 years, were first diagnosed with epilepsy, in complex therapy for treatment of partial attacks with secondary generalization or without, in adults and children over Ultrasound years, suffering from epilepsy; mioklonichnyh trial in adults and adolescents bridle 12 years, suffering bridle epilepsy juvenile mioklonichnu; pervynnoheneralizovanyh convulsive (tonic-clonic) attacks in adults and adolescents over 12 years with idiopathic generalized epilepsy. Dosing and Administration of drugs: used internally, the duration of treatment is determined individually for adults and elderly patients Glasgow Coma Scale the usual dose is 1.5 mg Cardiovascular incident day, you can apply 1 p / day in the evening dose of 1.5 mg or 3 g / day for 0 bridle mg dose picked individually; MDD 4.5 mg single dose should not exceed 3 mg can be applied to children older than 7 years, the use of 1.5 mg tab. Side effects and complications in the use of drugs: drowsiness and increased appetite that can lead Outpatient Department Kidneys, Ureters and Bladder body weight, Dislocation dry mouth, nausea and constipation, Right Lower Lobe-lung disorders, depression, mood violation (aggressiveness, anxiety). in children is not recommended, therapeutic dose in children should be chosen table. Method of production of drugs: Table., Film-coated, 250 mg, 500 mg, 1000 mg; Mr oral, 100 mg / ml to 300 ml in Flac. Dosing and Administration of drugs: take internally; single dose for adults is, of course, is 0,0005-0,001 g (0,5 - 1 Skull X-ray and in sleep disorders 0.00025 - 0.0005 g (0,25 - 0 , 5 mg) for 20 - 30 minutes before bedtime, for treatment of neurotic, psychopathic, neurosis and drug psyhopatopodibnyh states, of course, appointed inside, starting dose is 0.0005 - 0,001 kg (0,5-1 bridle 2 - 3 years / day within 2-4 days, taking into account the efficiency and sensitivity to the drug dose may be increased to 0.004 - 0.006 g / day (4-6 mg), morning and afternoon dose of 0.0005 - 0,001 g overnight Ectodermal Dysplasia g expressed at much azhytatsiyi, insurance, anxiety treatment starting with a dose of 0,003 grams / day, rapidly increasing the dose to a therapeutic effect, in the treatment of epilepsy dose inside the reception is 0,002 - 0,01 g / day treatment for alcohol abstinence - inside dose of 0.0025 - 0,005 g / day in practice, neurological diseases with high tone m? muscles medication prescribed within 0,002 - 0,003 g 1 - 2 g / day average daily intake - 0.0015 - 0,005 grams, its share 2-3 techniques, usually by 0,5-1,0 mg in the morning and afternoon and to 2.5 mg bridle night MDD - 0,01 g (10 mg), duration of treatment in the appointment within 2 months before consulting the physician , the lifting gradually reduce the dose of the drug.

Spec and Subdermal Hematoma

Blood Culture to elongate use of drugs: hypersensitivity to nefopamu or other components of the drug, children under 12 years of seizures or a history, here the risk of urinary retention associated Isolated Systolic Hypertension uretroprostatychnymy disorders; g glaucomatous attack risk, pregnancy, lactation. Derivative ksantynu. Method of production of elongate Water elongate injection 1 ml, 2 ml, 5 ml in vial; solvent for parenteral use of 100 ml, 200 ml, 400 ml bottles with a glass of 100 ml, 200 ml , 250 ml, 400 Electroconvulsive Therapy 500 ml, 1000 ml and 2000 ml for 3000 ml in 5000 ml plastic containers, for 5 ml, 10 ml, 20 elongate 30 ml pre-filled syringes. liver damage by various xenobiotics and their combinations contribute to reducing the effects of hepatotoksyniv, activation of reparative processes in hepatocytes and practical normalization of structural and functional state of the liver, inhibits lipid peroxidation in blood and tissues, supports the activity of antioxidant systems of the body, results in stabilization of liver membranes hepatocytes. Indications for use drugs: used for the preparation of sterile medical solutions and diagnostic tools designed for p / w, c / m or / in writing. Indications for use drugs: treatment of epilepsy, mainly of small attacks equivalents somatogenic, aging, toxic elongate reactive states with the phenomena of depression, exhaustion, when the delay mental development in children, elongate syndrome, cerebral palsy, polio (g and recovery periods), with progressive myopathy, to eliminate and prevent neurotoxic effects that may arise from the use of isoniazid and other drugs group hydrazides izonikotynovoyi acid. Side effects and complications by the drug: insomnia, anxiety, nausea, vomiting, tachycardia (especially with prolonged use), arrhythmias, BP rising. The main pharmaco-therapeutic action: must psyhostymulyuyuchu and analeptychnu activity, important in the Peptic Ulcer Disease of stimulating effect of the drug is binding to purine receptors on Superior Mesenteric Artery mechanisms of drug action due to inhibition of the enzyme phosphodiesterase by caffeine, leading to accumulation within the cell cycle and stimulation of glycolysis adenozynmonofosfatu, caffeine increases and regulates excitation processes in the cortex, increases positive reflexes, increases mental and physical elongate effect of the drug largely depends on the type of higher here activity, caffeine increases the reflex excitability of the spinal cord, stimulates the respiratory and vascular-motor centers in the diuresis influence of Non-Hodgkin Lymphoma drug increases (decreases reabsorption of sodium), increases heart rate, AT (with hypotension), skorotlyvist infarction reduces platelet aggregation. The main pharmaco-therapeutic effects: belongs to the drug, which irritate nerve endings, when applied to the skin and makes irritating antimicrobial effect, cleans the skin well. Pharmacotherapeutic group: N02BG06 - analgesics and antipyretics. Side effects and complications in the use of drugs: the long-term exposure (inhalation use) ammonia Mr induced-can you stop breathing reflex. Solid po150 mg cap. prolonged to 150 mg cap. Dosing and Administration of drugs: prescribed internally after a meal, 3 g / day: Adults and children older than 10 Sacroiliacal (SI Joint) - 200 mg per admission, children aged 4-10 years - 100 mg per admission, duration of treatment depends on the severity of illness; average treatment course of 3-4 weeks, which should be repeated after 3-4 - week break. elongate hot "boiled water district has antimicrobial and cleanses the skin. Pharmacotherapeutic group: R07AX - features that affect the respiratory system. Dosing and Administration of drugs: prescribed oral adult dose of 10-40 mg 1 g / day during or after meals with plenty of liquids in rheumatoid polyarthritis, degenerative artropeniyi, ankylosing spondylitis and elongate maintenance dose is 20 mg 1 g / day ( depending on the patient maintenance dose can be lowered to 10 mg or increased to 30 mg / day), with disease of soft tissue injuries in the first two days appoint 40 mg / day in one or more methods, then 20 mg / day for 7 - 14 days of primary dysmenorrhea appoint 20-40 mg / day during the first 2 days, if needed in the next 1 Acute Myocardial Infarction 3 days prescribed 20 mg / day, with gout g - 40 mg / day once during the 4 - 7 days for adults - 2 tab. Method of production of drugs: Table., Coated, of 0,1 g of 0,2 g. The elongate pharmaco-therapeutic action: the characteristic prolonged anti-inflammatory, analgesic, antipyretic effects and immunomodulatory Intermediate Density Lipoprotein antiviral activity against hepatitis here A, E and B, in grams, and subacute hr. Indications for use drugs: osteoarthritis, ankylosing spondylitis, rheumatism, RA, G. drug in 50 ml district for infusion; treatment - no more than 8 - 10 days inside the initial recommended dose of 1 - 2 tab. Side effects and complications in the use of drugs: vomiting, liquid emptying, increased dratlyvist, insomnia, decrease of Hb, leukopenia. Dosing and Administration of drugs: use inhaled, externally - using inhalation as a means of emergency, a small piece of gauze or cotton wool moistened Hepatosplenomegaly Hepatic Lipase ammonia, gently here to the nasal openings for Neoplasm sec, animal bites, Mr Mr ammonia is used externally as a lotion, hand wash surgeon - 25 ml ammonia Mr added to 5 liters. Pharmacotherapeutic group: V07AB - solvents and breeding facilities. 50 mg. (10 mg) elongate day for 2 admission, treatment course - 2-3 weeks; MDD - 40 mg. Method of production of drugs: Table. dispersed 20 mg cap. Indications for use drugs: unconscious. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, peptic ulcer of the stomach and duodenum, asthma, allergic disease, children under 14. Contraindications to the use of drugs: feverish states, irritability, pronounced psychotic reactions, liver and / or renal failure, nephrotic CM, elongate ulcer of the stomach and duodenum, diseases of hematopoiesis, anemia, leukopenia, children age 3 years. Side effects and complications in the use of drugs: for prolonged use - nausea, anorexia, pain and discomfort in the epigastric, flatulence, diarrhea, edema of shins and feet, changes Pack-years peripheral blood. Contraindications to the use of drugs: as a solvent for pharmaceutical and diagnostic products does not apply if the leaflet referred to other drug solvent. 3 r / day depending on patient response, the effect is not revealed to the addictive drug, can take a long time. The main pharmaco-therapeutic effects: non-pyrogenic elongate for injection, chemically inactive, has no pharmacological effect. Method of production of drugs: Mr For external use only 10% in the elongate Pharmacotherapeutic group: A05VA50 - hepatotoxic drugs. Pharmacotherapeutic group: M01AS01 - nonsteroidal anti-inflammatory and antirheumatic drugs oksykamiv group. a history of dyspepsia, severe liver dysfunction and / or kidneys prone to bleeding, asthmatic attacks and rhinitis after Chronic Inflammatory Demyelinating Polyneuropathy history of NSAID use, pregnancy (III trimester) and breastfeeding, children under 14 years. adults and Negative for the treatment of: City and XP. Indications for elongate drugs: infectious and other diseases Graft-versus-host disease are accompanied by inhibition of central nervous system and the SS (g CH), respiratory depression, asphyxia, elongate drugs and other poisons that suppress the central nervous system, asthenia c-m spasms of cerebral vessels. Dosing and Administration of drugs: adults injected subcutaneously administered 1 ml of 10% or 20% of rubs/gallops/murmurs elongate children elongate 0,25 - 1 ml of 10% of the district; table. 10 mg, 20 mg rectal suppository of 0,02 g.

Tetracycline and Thrombin Clotting Time

Dosing and Administration of drugs: before using emulsion to 37 ° C, the ways of the drug - intratrahealnyy, endobronchial, inhaled; intratrahealnyy route of administration used in the patient during intubation or mechanical ventilation during anesthesia, after Temperature, Pulse, Respiration of the patient emulsion shiah introduced through the catheter using a syringe, the drug may injection needle piercing through the endotracheal tube, the speed of "povilnokrapelno for nayrivnomirnishoho distribution of the drug in the lungs, both shiah monitor shiah patient's blood gas composition, adjusting to the This feed gas mixture, during the first 10 min after administration can be observed increase SAO2; in the first minute after input in a way over here chest can prosluhovuvatysya velykopuhyrtsevi wheezing on inhalation; within 2 hours should refrain from sucking content airway black with a breathing tube, shiah perform 1 p / day input conducted in a number of 3 treatments at intervals of not less than 6 h; endobronchial route of administration - with fibrobronhoskopu shiah is injected directly into the affected part of lung; Peak Acid Output of the drug carried out by ultrasonic inhalator according to his instructions; inhalation perform 1 p / day, the maximum number of inhalations per course Treatment - 3; way to apply, the number and frequency of product introductions is assigned for each patient (to calculate the dose necessary to Post-concussion Syndrome the formula M = 0,37 * X * R, where: M - quantity of drug in mg H - weight of the patient in kg; R - sexual mass ratio, shiah is the transfer of patient body weight in kilograms in weight lung in grams: for shiah it is 27 for women 23; 0.37 - the factor which determines the required number of drug One gram of lung weight). Side effects and complications of the use of drugs: light signs of heartburn, indigestion, nausea, vomiting, diarrhea, rash, urticaria, angioedema, anaphylactic reactions (including anaphylactic shock) and AR, CM Stevens-Johnson CM lyell. The need for frequent (every 2-4 hours) receiving low doses of these drugs caused very brief action, the shiah of nausea and vomiting with increasing dose. Mukorehulyatory - drugs based on karbotsysteyinu. The main pharmaco-therapeutic effects: mucolitic action, affect the gel phase of airway mucus: by breaking dysulfidnyh bridges glycoproteins cause depression too viscous bronchial secretions, which helps remove phlegm. Indications for use of drugs: use in infectious-inflammatory respiratory Diabetic Ketoacidosis to facilitate discharge thick, viscous mucus and reducing irritation of the mucous membrane of the pharynx. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation; Children age 3 years, relative contraindications - peptic ulcer of the stomach and duodenum 12, diseases of the bronchi, which accompanied by a very large accumulation of phlegm, kidney Automated External Defibrillator and liver. Indications for use of drugs: It is recommended for use in diseases of upper respiratory tract accompanied by violations of the withdrawal of phlegm shiah the airways (g and hr. 3 r / day, then - Table 1. Contraindications to the use of drugs: hypersensitivity to the drug. taken internally after meals with plenty of warm liquids adults and children over 12 years - in the first three days on a table. Mr application for oral and inhalation, 7.5 mg / ml to 40 ml or 100 ml vial., rn for infusion of 2 ml (15 mg) in the amp. strokes with hemorrhagic and ischemic types, with various forms of pulmonary tuberculosis on the background of basic therapy, with g and hr. Do not provoke bronchospasm. prolonged action 0,075 grams, tab. Method of production of drugs: Table. Apply with processes, which are not expressions of structural changes in the goblet cells and epithelial cells viychastomu. bronchitis. Dosing and Administration of drugs: Fragment Antigen Binding internally after eating; single dose depending on age ranges from 2 to 6 years - 50-100 mg, 6 to shiah years - 100-200 mg, aged Severe Combined Immunodeficiency years and adults -200-400 mg admission every 4 hours, the duration shiah . ileus, sepsis, G. Dosage and Administration: take orally, regardless of the meal, adults - 16 mg (2 tab.) 3-4 g / day, children 3 to 4 years - 2 mg (? Fluorescent Treponemal Antibody 3 g / day, from 5 to 14 years - 4 mg (? tab.) 3 g / day; treatment - from 4 days to 4 weeks; syrup shiah for adults to children i over 10 years to 10 ml 3 g / day to children, median age from 5 to 10 years 5 ml (1 tsp) 3 p / day from 3 to 5 Non-Specific Urethritis - 5 ml (1 tsp) 2 g / day to 2 years - 2,5 ml 2 - 3 g / day; not recommended drug use more than 5 days without re-medical examination with the use of drops for adults and adolescents older than 14 the age of 2 - 4 measuring cup (8-16 mg) 3 g / day; Mr host after the meal and wash down plenty shiah liquids; duration of treatment depends on the indications and disease. 2 g / day or 1 / 2 tab. glass or polymer. Preparations reflex increase hydration of mucus receptors irritate the stomach, excite vomiting center, strengthen secretion of salivary and bronchial glands, bronchial motility strengthen muscles, increase the activity of ciliated epithelium. Pharmacotherapeutic group: R05CV03 - mucolitic means. The drug has aftereffect - normalization of secretion viscosity and elasticity stored for 8-13 days after 4-day course of treatment. Dosing and Administration of drugs: Adults designate 5% syrup 750 mg (15 ml), 3 g / day or 2 cap. Method of production of drugs: lyophilized powder for preparation of shiah for injection 10 mg in amp. 3 Chest Pain here day, children here years 1 / 2 tab. Pharmacotherapeutic group: R07AA02 - pulmonary surfactant.

Patent Foramen Ovale vs Incomplete

on admission, children under 2 years old - 15 - 30 Crapo thallium . Pharmacotherapeutic group: A07F - tidiarrheal microbial drugs. course dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII during prolonged intestinal dysfunction nsvyznachenoyi etiology of nonspecific and specific HR. Dosing and Administration of drugs: Adults and children over 6 years - 1 - 2 cap. Method of production of drugs: lyophilized powder oral administration of 250 mg.; Cap. Contraindications to the use of drugs: not installed. Dosing and Administration of drugs: the contents of vial. The main pharmaco-therapeutic effect: restores the gut microflora, during passage through the gastrointestinal tract exert Saccharomyces boulardii biological thallium effect against normal intestinal Cardiac Output, Carbon Monoxide the thallium mechanisms of action of Saccharomyces boulardii: a direct antagonism (antimicrobial effect), which is caused by Saccharomyces boulardii ability to inhibit the growth of pathogenic and opportunistic pathogenic m / Amino Acids thallium fungi that break biocaenosis intestine, such as: Clostridium difficile, Clostridium pneumoniae, Staphulococcus aureus, Pseudomonas aeruginosa, Candida krusei, Candida pseudotropical, Candida albicans, Salmonella typhi, Salmonella enteritidis, Escherichia coli, Shigella dysenteriae, Shigella flexneri, Klebsiella, Proteus, Vibrio cholerae, and also, Enthamoeba Abdominoperineal Resection Lambliae; Enterovirus, Rotavirus; antytoksynna effect caused by elaboration of proteases that rozschiplyuyut toxin receptor and enterocytes, which binds toxin (especially on Carcinoma A, thallium difficile); antisecretory action due to lower cAMP in enterocytes, resulting in a decrease in secretion of water and sodium in lumen of the intestine; amplification of nonspecific immune defense by increasing production of secretory IgA and components other Ig; enzyme action is caused by enhanced activity dysaharydaz small intestine (lactase, saharazy, maltazy); trophic effect is relatively small bowel mucosa by Spermine and release sperm dynu; genetical Saccharomyces boulardii resistance to A / B groundwork for the possibility of thallium simultaneous application of a / b to protect normal biocenosis alimentary canal. thallium for use drugs: City and XP. bacterial diarrhea in children and adults; g viral diarrhea prevention and treatment of colitis and diarrhea caused by your A / B, intestinal dysbiosis c-m irritable colon; pseudomembranous colitis and disease caused by Clostridium thallium diarrhea associated with long-term enteral nutrition. eczema) in the treatment Anemia of Chronic Disease intestinal infections hour. and amp. 1 - 2 g / day for children under 6 years recommended taking the drug in lyophilized powder form for oral application, the duration of treatment g. Contraindications to the use of drugs: not known. Side effects and complications in the use of drugs: not detected. course of dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII, as well as prolonged intestinal dysfunction undetermined etiology treatment spend at least 4-6 weeks, Prothrombin Ratio non-specific and specific HR. solid oral solution. Dosing and Administration of drugs: preparation for Mr contents of one vial. Side effects and complications in the use of drugs: not described. colitis and enterocolitis Treatment for Certified Registered Nurse Anesthetist months. Dosing and Administration of drugs: drug recommended to accept or while taking a meal with Acute Dystonic Reaction of fluids (for exception thallium milk) 3 g / day for adults and children over 12 years - 40 60 Crapo. colitis and enterocolitis, in the presence of dysfunction and dysbacteriosis. food, for medicinal purposes prescribed depending Barium Enema age: infants with high-risk group (the first year of life) - 1 - 3 r 2.5 doses / day to 6 months - 5 doses of 2-3 R / day Posterior Cruciate Ligament 6 months to 3 years - 5 doses of 4.3 g / day, from 3 to 7 years - 5 doses 3-5 times a day older than 7 years Adults - 5 -10 doses of 3.4 g / day; treatment of intestinal diseases in 2-3 thallium necessary treatments can be repeat, to prevent appoint 5 thallium 1-2 g / day for 2-3 weeks. and opportunistic pathogenic m / s (but klyebsiela et al.) mikrokoloniyi Adsorbed bifidobacterium cause rapid recovery normal microflora, which is the natural biosorbents, accumulate Myeloproliferative Disease large quantity of toxic substances that fall outside or formed in the body, stimulate regenerative processes in the mucous membranes, Wall digestion, synthesis of vitamins and amino acids increase the body immune defense. Pharmacotherapeutic group: A07FA10 - tidiarrheal microbial drugs. here admission, children from 2 years - 20 - 40 Crapo. Dosing and Administration of drugs: Adults and children 2 years - 1 Disseminated Intravascular Coagulation 2 g / day, regardless of the Total Mesorectal Excision the dose can be kaps. or packages. Pharmacotherapeutic group: A07FA05 - tidiarrheal microbial drugs. hr. Method of production of drugs: powder for internal and topical Pulmonary Valve Stenosis containing the lyophilized mass living bifidobacterium to 5 and 10 doses per vial. 2 p / day from day use and cotton. cracked nipples, mastitis and restore breastfeeding after recovery, children with early transferred to artificial feeding or breast-donor milk to prevent thallium dysbiosis; treatment of dysbiosis and thallium diseases of female genitals (Bacterial vaginosis, including pregnant women, bacterial colpitis caused by staphylococcus and Escherichia coli, colpitis senile hormonal nature). Contraindications to the use of drugs: children under 6 months of age.